KIF1A

FEBRUARY 24, 2024

#ScienceSaturday posts share exciting scientific developments and educational resources with the KAND community. Each week, Dr. Dylan Verden of KIF1A.ORG summarizes newly published KIF1A-related research and highlights progress in rare disease research and therapeutic development. KIF1A-Related Research A Model for Chemomechanical Coupling of Kinesin‑3 Motor Like humans, KIF1A pairs walk one step at a time, one foot in front of the other.

Disease 111

Disease Research Treatment Science 111

Drugs.com

FEBRUARY 24, 2024

SATURDAY, Feb. 24, 2024 (HeathDay News) -- Colon cancer rates are on the rise among young Americans and Americans of color, so much so that the disease is now the leading cause of cancer death for men under 50 and the second most deadly cancer for.

Disease 75

Disease 75

Drug Patent Watch

FEBRUARY 24, 2024

This chart shows the companies which have received the most New Combination exclusivities in the past five years. New Combinations are one of the categories for which the FDA grants… The post Pharmaceutical companies with the most ‘New Combination’ drugs appeared first on DrugPatentWatch - Make Better Decisions.

Pharmaceutical Companies 45

Pharmaceutical Companies Pharmaceuticals Drugs FDA 45